What Is Amine-Reactive Antibody Conjugation?
Amine-reactive antibody conjugation is a widely practiced bioconjugation strategy that exploits the primary amine groups naturally present on antibody molecules as chemical handles for covalent payload attachment. Every antibody contains dozens of lysine residues whose epsilon-amino groups, together with the N-terminal alpha-amine of each polypeptide chain, serve as nucleophilic sites that react with activated ester, isothiocyanate, or carbodiimide-activated carboxyl reagents. This chemistry has powered the vast majority of commercial fluorescent antibody labeling kits, enzyme-antibody conjugate production for ELISA and western blot detection, and biotin-antibody conjugation for affinity-based applications.
The dominance of amine-reactive chemistry in antibody labeling stems from its practical advantages. Lysine residues are abundant and distributed across the antibody surface, meaning that no prior reduction or enzymatic treatment is required before conjugation. The reaction proceeds rapidly under mild aqueous conditions at pH 7.0-9.0, compatible with antibody structural integrity. Commercial reagents are available with a wide variety of functional cargo including fluorophores spanning the visible to near-infrared spectrum, horseradish peroxidase (HRP), alkaline phosphatase (AP), biotin, and numerous small-molecule tags. The trade-off for this simplicity is heterogeneity: because lysines are distributed across the entire antibody surface, amine-reactive conjugation produces a distribution of conjugate species with varying numbers and locations of attached payloads. For many research applications, this heterogeneity is entirely acceptable, and the speed and accessibility of the chemistry far outweigh the loss of molecular definition.
Target functional groupsPrimary amines on lysine side chains (epsilon-amine, pKa approximately 10.5) and N-terminal amino groups (alpha-amine, pKa approximately 7.6-8.0). At the typical reaction pH of 7.5-9.0, a significant fraction of these amines are deprotonated and nucleophilic, enabling efficient acylation or thiourea formation.
Abundance on antibodiesA typical IgG molecule contains 60-90 lysine residues, of which approximately 30-40 are solvent-accessible and available for conjugation. The N-terminus of each heavy and light chain adds four additional reactive amines per antibody molecule.
Reaction requirementsAmine-free buffer (PBS pH 7.4, carbonate pH 8.3-8.5, or borate pH 8.5), purified antibody at 1-10 mg/mL, and a molar excess of the amine-reactive reagent (typically 5-20 fold). Reaction completion within 1-4 hours at room temperature or overnight at 4 degrees C.
Primary applicationsFluorescent antibody labeling for flow cytometry and microscopy, HRP and AP conjugation for ELISA and western blot, biotinylation for streptavidin-based detection and affinity purification, and small-molecule drug conjugation for research-grade antibody-drug conjugates.
Chemistry of Amine-Reactive Conjugation
The three principal amine-reactive chemistries, NHS ester acylation, isothiocyanate addition, and EDC-mediated amide bond formation, share the common feature that they all target primary amine nucleophiles, but they differ substantially in their reaction mechanisms, kinetics, byproduct profiles, and the stability of the resulting linkage. Understanding these differences is essential for selecting the right chemistry for a given antibody-payload combination and for troubleshooting when conjugation results fall short of expectations.
Nucleophilic Attack: The Unifying Principle
At the molecular level, all amine-reactive conjugation chemistries proceed through nucleophilic attack by the unprotonated primary amine on an electrophilic carbon center in the reactive reagent. The amine lone pair of electrons attacks the carbonyl carbon of an NHS ester, the central carbon of an isothiocyanate group, or the activated carboxyl carbon of an EDC-generated O-acylisourea intermediate. The rate of each reaction depends on the fraction of amines that are deprotonated at the working pH, the electrophilicity of the reactive carbon, the leaving group ability of the displaced moiety, and the susceptibility of the reactive reagent to competing hydrolysis in the aqueous reaction medium.
Key Differences Among the Three Chemistries
NHS esters react rapidly with amines to form stable amide bonds, releasing N-hydroxysuccinimide as a benign leaving group. Their primary limitation is susceptibility to hydrolysis in aqueous solution; the half-life of an NHS ester in pH 8.0 buffer at room temperature is typically 10-60 minutes, depending on the specific ester and solution conditions. Isothiocyanates react more slowly but exhibit greater hydrolytic stability, making them more forgiving in aqueous buffers. The resulting thiourea linkage is chemically stable but introduces a spacer that can participate in nonspecific hydrophobic interactions. EDC-mediated coupling differs fundamentally: rather than using a pre-activated reagent, EDC activates carboxyl groups present on the payload molecule, forming an amine-reactive O-acylisourea intermediate in situ. This "zero-length" crosslinking strategy produces a direct amide bond between the payload carboxyl and the antibody amine, with no additional spacer atoms introduced by the coupling chemistry itself.
| Property | NHS Ester | Isothiocyanate | EDC/NHS Coupling |
|---|
| Reactive group | Activated carboxyl ester | Isothiocyanate (-N=C=S) | EDC-activated carboxyl |
| Reaction product | Stable amide bond | Stable thiourea bond | Stable amide bond (zero-length) |
| Reaction pH optimum | 7.2-8.5 | 9.0-9.5 | 4.5-7.2 (two-step: activate at pH 4.5-5.5, couple at pH 7.2-7.5) |
| Aqueous half-life | 10-60 min at pH 8.0, RT | Hours at pH 9.0 | Seconds to minutes (O-acylisourea) |
| Reaction rate with amines | Fast (minutes to hours) | Moderate (hours) | Fast once activated |
| Hydrolysis susceptibility | High (competing reaction) | Low | Very high (requires NHS stabilization) |
| Common reagents | NHS-fluorescein, NHS-biotin, NHS-rhodamine, Alexa Fluor NHS esters | FITC, TRITC | EDC plus NHS plus carboxyl-containing payload |
| Typical applications | Fluorescent labeling, biotinylation, enzyme conjugation | FITC antibody labeling for microscopy and flow cytometry | Conjugation of carboxyl-containing drugs, peptides, or linkers |
NHS Ester Conjugation: Mechanism and Protocol
NHS ester chemistry is the most frequently employed method for antibody labeling in research laboratories. The NHS (N-hydroxysuccinimide) ester is a carboxyl group activated for nucleophilic attack; when an amine reacts with the ester carbonyl, the NHS moiety is released and an amide bond is formed between the payload and the antibody lysine residue. Commercial NHS ester reagents are available with an enormous variety of fluorescent dyes, biotin variants, and enzyme-reactive crosslinkers, making this chemistry the default starting point for most antibody conjugation projects.
Reaction Mechanism
The NHS ester reaction proceeds in a single step: the primary amine attacks the carbonyl carbon of the ester, forming a tetrahedral intermediate that collapses to release N-hydroxysuccinimide and generate the amide product. The rate of this reaction is pH-dependent, increasing as the pH rises above 7.0 because a larger fraction of amine groups are deprotonated and nucleophilic. However, the competing hydrolysis reaction, where water attacks the NHS ester instead of the amine, also accelerates at higher pH. The practical optimum for most NHS ester conjugations is pH 8.0-8.5, where the amine reactivity is sufficiently high but hydrolysis has not yet become prohibitively fast.
Standard NHS Ester Labeling Protocol
The antibody should first be buffer-exchanged into an amine-free buffer such as 0.1 M sodium bicarbonate (pH 8.3-8.5) or 0.1 M sodium borate (pH 8.5) using a desalting column or dialysis. The antibody concentration should be adjusted to 1-10 mg/mL. The NHS ester reagent is dissolved in anhydrous DMSO or DMF immediately before use, typically at 10-20 mg/mL. A 5-20 fold molar excess of the NHS ester reagent is added to the antibody solution with gentle mixing, and the reaction is incubated for 1-2 hours at room temperature protected from light. After incubation, unconjugated free dye or payload is removed by size-exclusion chromatography using a desalting column pre-equilibrated with PBS. The degree of labeling is calculated from the absorbance spectrum of the purified conjugate.
Buffer selectionUse 0.1 M sodium bicarbonate (pH 8.3-8.5) or 0.1 M sodium borate (pH 8.5). Avoid Tris, glycine, ammonium salts, and any primary amine-containing buffer components. PBS at pH 7.4 can be used when the higher pH is not tolerated by the antibody, but reaction efficiency may be reduced.
Reagent preparationDissolve the NHS ester in anhydrous DMSO or DMF at 10-20 mg/mL. Prepare immediately before use; do not store the dissolved reagent. The organic solvent content in the final reaction should not exceed 5-10 percent to avoid antibody denaturation.
DOL controlThe molar ratio of NHS ester to antibody determines the final DOL. For fluorescent dyes, start with a 10-15 fold molar excess and titrate in subsequent experiments. Typical target DOL values are 2-6 for fluorophores and 3-6 for biotin.
PurificationRemove free dye by size-exclusion chromatography (desalting column, PD-10 or Zeba Spin) or extensive dialysis. Monitor column fractions by absorbance at both 280 nm and the dye absorption maximum to confirm separation of conjugate from free payload.
Isothiocyanate Conjugation: FITC and Beyond
Isothiocyanate-based conjugation, exemplified by fluorescein isothiocyanate (FITC), was among the earliest antibody labeling chemistries developed and remains in widespread use today for fluorescent antibody preparation. Isothiocyanates react with primary amines to form stable thiourea linkages, offering distinct advantages in aqueous stability and reaction control compared to NHS esters, at the cost of somewhat slower reaction kinetics and a higher optimal pH.
The Isothiocyanate-Amine Reaction
The isothiocyanate functional group (-N=C=S) contains a central electrophilic carbon flanked by nitrogen and sulfur. Primary amines attack this carbon, forming a thiourea bond (-NH-CS-NH-) that is stable under physiological conditions and resistant to hydrolysis. Unlike NHS esters, isothiocyanates are relatively stable in aqueous solution, with half-lives measured in hours rather than minutes at typical reaction pH. This stability simplifies handling and allows extended reaction times that can drive the conjugation closer to completion, but it also means that the reaction requires a higher pH (typically 9.0-9.5) to ensure sufficient deprotonation of the antibody amine groups for efficient nucleophilic attack.
FITC Conjugation Protocol
FITC is dissolved in anhydrous DMSO at 1-10 mg/mL immediately before use. The antibody is prepared in 0.1 M carbonate buffer at pH 9.0-9.5 at a concentration of 1-10 mg/mL. FITC is added at a molar ratio of 20-50 micrograms per milligram of antibody, equivalent to approximately a 10-30 fold molar excess depending on the antibody concentration. The reaction is incubated for 2-4 hours at room temperature or overnight at 4 degrees C with continuous gentle mixing and protection from light. Unconjugated FITC is removed by size-exclusion chromatography, and the conjugate is characterized by measuring the absorbance at 495 nm (FITC) and 280 nm (protein). The fluorescein-to-protein (F/P) ratio is calculated using the formula F/P = (A495 x dilution factor) / (protein concentration in mg/mL x 0.35), where 0.35 is an empirically determined correction factor.
FITC characteristicsExcitation maximum: 495 nm. Emission maximum: 519 nm. Quantum yield: approximately 0.5 in aqueous solution at pH 9.0. FITC fluorescence is pH-sensitive, with significantly reduced emission below pH 7.0, which must be considered in acidic intracellular compartments.
Thiourea linkage propertiesThe thiourea bond is chemically stable and not susceptible to hydrolysis under biological conditions. However, the thiocarbonyl group can participate in hydrophobic interactions and may contribute to nonspecific binding of the conjugate to hydrophobic surfaces or proteins.
Optimal F/P ratioFor most immunofluorescence applications, an F/P ratio of 2-5 is optimal. Ratios below 1 produce weak signal, while ratios above 6 can cause fluorescence quenching through fluorophore-fluorophore interactions and increased nonspecific staining.
TRITC and other isothiocyanatesTetramethylrhodamine isothiocyanate (TRITC) offers an alternative emission wavelength (approximately 575 nm) with better photostability than FITC but lower quantum yield. The conjugation protocol is similar to FITC, with the F/P ratio calculated using the appropriate extinction coefficient.
EDC-Mediated Coupling: Zero-Length Crosslinking
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) coupling occupies a distinct niche among amine-reactive conjugation strategies. Unlike NHS ester and isothiocyanate reagents, which are pre-activated payload molecules, EDC activates carboxyl groups present on the payload in situ, generating a highly reactive O-acylisourea intermediate that can be attacked by antibody amines. This approach is particularly valuable when the payload of interest contains a carboxyl group but no pre-activated amine-reactive functionality, as is the case for many small-molecule drugs, peptide antigens, and carboxyl-modified nanoparticles.
EDC Activation and NHS Stabilization
The EDC reaction begins with activation of a carboxyl group on the payload molecule. EDC reacts with the carboxyl to form an O-acylisourea intermediate, which is highly electrophilic and susceptible to nucleophilic attack by amines, yielding a stable amide bond and releasing the EDC byproduct as a soluble urea derivative. The critical challenge in EDC-mediated conjugation is the extremely short aqueous half-life of the O-acylisourea intermediate, which hydrolyzes within seconds to minutes at neutral pH. To address this instability, EDC coupling is almost always performed in the presence of NHS or sulfo-NHS. The NHS converts the O-acylisourea into a more stable NHS ester intermediate in situ, which then reacts with antibody amines on a timescale of minutes to hours. This two-step activation strategy dramatically improves conjugation efficiency compared to EDC alone.
Two-Step EDC/NHS Coupling Protocol
In a typical protocol, the carboxyl-containing payload is dissolved in activation buffer (0.1 M MES, pH 5.0-6.0, or 0.1 M phosphate, pH 6.0) at 1-10 mg/mL. EDC and NHS are added at a 1:1 to 1:2 molar ratio relative to the carboxyl groups, and the mixture is incubated for 15-30 minutes at room temperature to form the NHS ester intermediate. Excess EDC is quenched by the addition of 2-mercaptoethanol at a final concentration of 10-20 mM. The activated payload is then added to the antibody solution in coupling buffer (0.1 M phosphate or carbonate, pH 7.2-7.5) and incubated for 2-4 hours at room temperature or overnight at 4 degrees C. The conjugate is purified by size-exclusion chromatography to remove unreacted payload, EDC byproducts, and NHS.
Zero-length advantageEDC coupling produces a direct amide bond between the payload carboxyl and the antibody amine with no additional spacer atoms. This minimal linkage is valuable when the biological activity of the payload depends on close proximity to the antibody surface.
pH sensitivityThe activation step requires acidic pH (4.5-6.0) for efficient EDC reactivity, while the coupling step requires near-neutral to slightly basic pH (7.2-7.5) for amine nucleophilicity. This two-pH requirement demands careful buffer management during the protocol.
Potential side reactionsIf the payload contains both carboxyl and amine groups, EDC can induce payload self-polymerization. To minimize this, use a large molar excess of NHS over the payload carboxyl groups and keep the payload concentration low during activation.
Common applicationsConjugation of carboxyl-containing haptens, peptide antigens, chelating agents, and small-molecule drugs to carrier proteins or antibodies. Also useful for carboxylated nanoparticle or polymer conjugation to antibody surfaces.
Optimizing Amine-Reactive Conjugation Parameters
Achieving a reproducible, high-quality amine-reactive antibody conjugate requires systematic optimization of several interdependent variables. The most critical parameters are the molar ratio of the amine-reactive reagent to antibody, the reaction pH and buffer composition, the reaction time and temperature, and the choice of purification method. A structured approach to optimization, starting with small-scale pilot reactions before scaling to the full conjugation batch, is strongly recommended for all projects.
The goal of optimization is not simply to maximize the number of payload molecules attached to the antibody, but to find the conditions that produce a conjugate with the optimal balance of signal intensity, binding activity, and solubility for the intended application. Over-conjugation can be as problematic as under-conjugation, leading to fluorescence quenching, antibody precipitation, loss of antigen-binding affinity, and increased nonspecific binding in immunoassays.
| Parameter | Typical Range | Effect on Conjugation | Optimization Guidance |
|---|
| Molar ratio (reagent:antibody) | 5:1 to 30:1 | Higher ratios increase DOL but risk precipitation and quenching | Start at 10:1. If DOL is too low, increase to 15:1 or 20:1. If precipitation occurs at 20:1, reduce to 8:1. |
| Reaction pH | 7.0 to 9.5 | Higher pH increases amine nucleophilicity and NHS ester hydrolysis rate | NHS ester: pH 8.0-8.5. Isothiocyanate: pH 9.0-9.5. EDC activation: pH 5.0-6.0. EDC coupling: pH 7.2-7.5. |
| Reaction time | 30 min to overnight | Longer times increase DOL but may cause antibody aggregation | NHS ester: 1-2 hours at RT. Isothiocyanate: 2-4 hours at RT or overnight at 4 degrees C. EDC: 2-4 hours at RT. |
| Reaction temperature | 4 degrees C to 37 degrees C | Higher temperature increases reaction rate and hydrolysis rate | Room temperature (20-25 degrees C) is standard. Use 4 degrees C for temperature-sensitive antibodies; extend reaction time to compensate. |
| Antibody concentration | 1 to 10 mg/mL | Higher concentrations favor intermolecular reaction over hydrolysis | Concentrate antibody to at least 1-2 mg/mL for efficient conjugation. Concentrations above 10 mg/mL may cause aggregation during the reaction. |
| DMSO/DMF content | 1 to 10 percent v/v | Organic solvent solubilizes hydrophobic reagents but can denature antibody | Keep organic solvent below 5 percent v/v when possible. Add reagent solution slowly with mixing to avoid local high concentrations. |
| Quenching | Optional step | Stops the reaction by consuming residual reactive groups | Add 1 M Tris or 1 M glycine (pH 8.0) to a final concentration of 50-100 mM. Incubate 30 minutes before purification. |
Troubleshooting Amine-Reactive Conjugations
Even with careful protocol design, amine-reactive antibody conjugations can produce unexpected outcomes. Common problems include low DOL despite adequate reagent excess, antibody precipitation during or after the reaction, loss of antigen-binding activity after conjugation, high levels of nonspecific binding in downstream assays, and poor batch-to-batch reproducibility. Most of these issues can be traced to a small set of root causes related to buffer composition, reagent handling, antibody quality, or reaction stoichiometry.
Low degree of labelingCheck for amine-containing buffer components (Tris, glycine, ammonium) that compete with antibody amines. Verify that the NHS ester reagent was dissolved fresh in anhydrous solvent and used immediately. Confirm that the antibody was buffer-exchanged into an amine-free buffer before the reaction. If using a commercial labeling kit, check the expiration date of the reactive reagent.
Antibody precipitationPrecipitation during or after conjugation typically indicates that the DOL is too high, causing the antibody surface to become excessively hydrophobic. Reduce the molar ratio of reactive reagent to antibody by 30-50 percent. Ensure the organic solvent (DMSO or DMF) content does not exceed 5-10 percent. Add BSA at 1-2 mg/mL after purification as a stabilizing carrier protein for long-term storage.
Loss of binding activityIf conjugation significantly reduces antigen-binding affinity, lysine residues in or near the complementarity-determining regions (CDRs) may have been modified. Reduce the DOL to 2-4. Consider switching to a carbohydrate-directed or site-specific conjugation method. If amine-reactive chemistry must be used, pre-incubate the antibody with a substoichiometric amount of antigen to protect the binding site during conjugation.
High nonspecific bindingExcessive nonspecific binding in immunoassays often results from incomplete removal of free dye or payload, over-conjugation leading to hydrophobic conjugate species, or aggregation. Verify complete separation of conjugate from free payload by monitoring the UV-Vis spectrum across desalting column fractions. Use the lowest DOL that provides adequate signal. Include a blocking step with BSA or casein after labeling.
Amine-Reactive Conjugation Support from BOC Sciences
BOC Sciences provides comprehensive custom conjugation services using NHS ester, isothiocyanate, and EDC-mediated chemistries for research-scale antibody labeling projects. Our team evaluates each project individually to select or optimize the amine-reactive chemistry that best matches the antibody properties, payload characteristics, and intended application. From single-antibody fluorescent labeling to multi-conjugate panel production with defined batch specifications, our conjugation support spans the full project lifecycle from chemistry selection to purified, quality-controlled conjugate delivery.
NHS ester conjugation servicesCustom antibody labeling with NHS ester-activated fluorophores, biotin, HRP, alkaline phosphatase, and other functional molecules. Includes DOL optimization, purification, and QC with absorbance-based DOL measurement and functional activity verification.
FITC and isothiocyanate labelingFITC conjugation for flow cytometry and immunofluorescence microscopy, TRITC labeling for dual-color applications, and custom isothiocyanate-based labeling with F/P ratio optimization and post-labeling validation.
EDC-mediated conjugationConjugation of carboxyl-containing small molecules, peptides, haptens, and drug payloads to antibodies via EDC/NHS coupling, with buffer optimization, activation stoichiometry screening, and purification tailored to the conjugate properties.
Analytical characterizationUV-Vis spectroscopy for DOL determination, size-exclusion HPLC for aggregation analysis, SDS-PAGE for conjugate integrity, and ELISA or SPR-based binding activity assays to confirm that the conjugated antibody retains target recognition capability.
Need Custom Amine-Reactive Antibody Conjugation?
Whether you need FITC-labeled antibodies for a flow cytometry panel, NHS ester-based biotinylation for an affinity purification workflow, EDC-mediated conjugation of a carboxyl-containing drug payload, or batch production of fluorescent antibody reagents with defined DOL specifications, BOC Sciences provides application-matched amine-reactive conjugation services with purification, QC, and functional validation.
- NHS ester, isothiocyanate (FITC/TRITC), and EDC/NHS conjugation chemistries
- Fluorophore, biotin, enzyme (HRP, AP), and small-molecule payload labeling
- DOL optimization, free payload removal, and analytical QC
- Scalable from micrograms to grams with documented batch records
Frequently Asked Questions About Amine-Reactive Antibody Conjugation
What is amine-reactive antibody conjugation?
Amine-reactive antibody conjugation is a bioconjugation strategy that covalently attaches functional molecules to primary amine groups on antibody lysine residues and N-termini. The most common amine-reactive chemistries are NHS ester acylation, isothiocyanate addition (e.g., FITC), and EDC-mediated amide bond formation. These methods are widely used because they are fast, compatible with unmodified antibodies, and supported by an extensive range of commercially available reactive reagents.
What is the difference between NHS ester and isothiocyanate conjugation?
NHS esters react rapidly with amines to form stable amide bonds but are susceptible to hydrolysis in aqueous solution, with half-lives of 10-60 minutes at pH 8.0. Isothiocyanates react more slowly, forming stable thiourea linkages, but are more hydrolytically stable in water, with half-lives measured in hours. NHS ester reactions are typically performed at pH 7.2-8.5, while isothiocyanate reactions require a higher pH (9.0-9.5) for optimal amine nucleophilicity.
How is the degree of labeling (DOL) calculated for amine-reactive conjugates?
For fluorescent dye conjugates, the DOL is calculated from UV-Vis absorbance measurements at two wavelengths: the dye absorption maximum and 280 nm (protein). The protein concentration is corrected for dye absorbance at 280 nm using a correction factor specific to each fluorophore. The formula is DOL = (A_dye x dilution factor) / (protein concentration in molar units x extinction coefficient of the dye). For biotinylated antibodies, DOL is commonly determined using the HABA-avidin assay, which measures the displacement of HABA from avidin by biotin.
What buffer conditions are compatible with NHS ester conjugation?
NHS ester conjugation requires amine-free buffers. Suitable buffers include 0.1 M sodium bicarbonate (pH 8.3-8.5), 0.1 M sodium borate (pH 8.5), and PBS (pH 7.4) when a lower pH is needed. Buffers containing primary amines (Tris, glycine, ammonium salts), carrier proteins (BSA, gelatin), and preservatives such as sodium azide must be avoided because they consume the reactive NHS ester and reduce conjugation efficiency. The antibody should be buffer-exchanged into a compatible buffer by dialysis or desalting column before the reaction.
Does amine-reactive conjugation affect antibody binding activity?
It can, particularly if lysine residues within or near the complementarity-determining regions (CDRs) are modified. The risk of binding-activity loss increases with the degree of labeling. At DOL values of 2-4, most antibodies retain adequate binding activity. At DOL values above 6-8, some loss of affinity is more common. If maintaining full binding activity is critical, consider reducing the target DOL, using a carbohydrate-directed conjugation strategy that is remote from the antigen-binding site, or employing site-specific methods.
What is EDC coupling and when should it be used?
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) coupling activates carboxyl groups on the payload molecule to form an amine-reactive intermediate, enabling direct amide bond formation with antibody amines. It is the method of choice when the payload contains a carboxyl group but no pre-activated amine-reactive functionality, such as certain small-molecule drugs, peptide antigens, or carboxyl-modified surfaces. EDC is typically used together with NHS (or sulfo-NHS) to stabilize the reactive intermediate and improve conjugation efficiency through a two-step activation-and-coupling protocol.
How can I troubleshoot low conjugation efficiency?
Low conjugation efficiency is most commonly caused by competing amines in the reaction buffer, degraded or hydrolyzed reactive reagent, insufficient molar excess of reagent, or antibody at too low a concentration. Check that the antibody has been buffer-exchanged into an amine-free buffer. Prepare the reactive reagent fresh in anhydrous DMSO or DMF immediately before use. Verify that the reagent has not been exposed to moisture during storage. Increase the molar ratio of reagent to antibody in steps of 5:1 until the desired DOL is reached. If these steps do not resolve the issue, perform a pilot experiment with a small amount of a different antibody to determine whether the problem is antibody-specific.